COVID-19 information for clinicians

Image of hands of doctor and patient at desk. Links to: Information for clinicians regarding COVID-19 and epilepsy

It has become apparent that we are learning about the possible impact of COVID19; either on neurological status in previously normal individuals, or the impact on our patients with epilepsy.

Report cases
If you have cared for a patient who has experienced an exacerbation of seizures, developed new onset seizures, or experienced another neurological change, please add the case information to our dataset.

For clinicians involved in the care of patients with epilepsy with COVID19

Keeping people with epilepsy safe during the Covid-19 pandemic French et al. Neurology. April 2020

Useful COVID-19 references

ILAE survey for clinicians

We are trying to find out more about the impact of COVID19 on patient care of those with epilepsy. Please take two minutes to complete the following questions.

COVID-19 Survey for Clinicians. This survey is available translated into multiple languages.

Flags of nations representing languages into which the ILAE COVID-19 clinician survey has been translated

FAQs for clinicians

FAQs for Clinicians This survey is available translated into multiple languages.

Flags of countries representing the languages in which the FAQs are available

For epileptologists

Telemedicine in patients with epilepsy: What to ask for?

Video-EEG Telemetry for Epilepsy Surgery during COVID-19 Restrictions (ILAE Surgical Therapies Commission, August 2020)

Telemedicine for Epilepsy Care in the COVID-19 Era: key points to address + links to resources

COVID-19: Organization challenges with remote work in Epilepsy
Survey to assess both physician and patient satisfaction with telemedicine and organizational practices, and to determine in which situations telemedicine will have a more permanent role in our practice in the future.

Epilepsy Management During the COVID-19 Pandemic (YouTube)
Saudi Epilepsy Society Webinar, in English, recorded 4 April 2020
• J. Helen Cross: Epilepsy in the COVID-19 pandemic (overview) - starts at 7:50
• Emilio Perucca: Facing the COVID-19 crisis in an epilepsy center in Italy - starts at 29:00
• Haifa Alabri: Anti-epileptic drug interactions with drugs used for COVID-19 - starts at 44:26
• Zeyad Althani: Practical guide on ICU EEG monitoring for status epilepticus - starts at 57:37
• Question and answer period - starts at 1:14:20

Guidance on EEG investigations (American Clinical Neurophysiology Society)

Neuropsychological Assessments for Epilepsy Surgery during COVID-19 Restrictions

Optimizing Status Epilepticus care during the COVID-19 pandemic
Michael O. Kinney, Francesco Brigo, Peter W. Kaplan. Epilepsy & Behavior
[Also in Georgian: ეპილეფსიური სტატუსის მართვის ოპტიმიზაცია COVID-19 პანდემიის პირობებშიc]

Information in different languages

For clinicians involved in the care of patients with epilepsy with COVID19

Saudi Epilepsy Society Consensus on Epilepsy Management During the COVID-19 Pandemic Neurosciences 2020; Vol 25(3). doi: 10.17712/nsj.2020.3.20200066

COVID-19 Guidance for Clinicians from the ILAE Psychiatric Commission

COVID-19 and World Neurology (WFN):
Covid-19 resources, references, Global Neurology Alliance, more

Guidance for clinical neurophysiology examination throughout the COVID-19 pandemic. Latin American chapter of the IFCN task force. Daniel San-Juan et al. Clinical Neurology, V.131 (7).

Webinar recording on drug interactions - EpiCARE
Webinar topics:

  • Emilio Perucca – Neurological manifestations of COVID-19 and special concerns for people with epilepsy – starts at 1:40
  • Emilio Perucca - Drug interaction information – starts at 14:45
  • Cecelie Johannessen Landmark - Mechanisms of drug interactions – starts at 33:00
  • Eugen Trinka – 49:38 – Status epilepticus during COVID-19 pandemic – starts at 49:38
  • Q&A – starts at 1:19:49

Seizures in COVID-19

Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline
Zhikang Ye et al, CMAJ.

Information from WHO on immunity passports

(rev. 6/29/2020)